title: Novel antibodies against receptors, protein kinase inhibitors, and siRNA, targeting both signal transduction and gene expression, will certainly lead to the therapeutic approaches that will be developed and used in this new century. Preface.
authors.affiliation: Laboratoire de Biologie Moléculaire et Cellulaire du Cancer Hôpital Kirchberg, L-2540 Luxembourg.
authors.forename: Marc
authors.initials: M
authors.lastname: Diederich
mesh_terms: D000906:Antibodies / Q000276:immunology / Q000494:pharmacology* / Q000627:therapeutic use; D004358:Drug Therapy / Q000379:methods / Q000639:trends; D015870:Gene Expression / Q000187:drug effects*; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000235:genetics; D011956:Receptors, Cell Surface / Q000276:immunology; D015398:Signal Transduction / Q000187:drug effects* / Q000235:genetics / Q000502:physiology
chemical_list: D000906:Antibodies; D047428:Protein Kinase Inhibitors; D034741:RNA, Small Interfering; D011956:Receptors, Cell Surface